Cure My Disease

Don't miss your cure!

 Log in / Sign up

Watchful waiting or medication? new study tackles retained tissue after miscarriage

NCT ID NCT07534982

Recruiting now Disease control Sponsor: Yael Yagur Source: ClinicalTrials.gov ↗

First seen Apr 26, 2026 · Last updated Apr 28, 2026 · Updated 1 time

Summary

This study looks at two approaches for women who have leftover pregnancy tissue in the uterus after a first-trimester miscarriage or medication abortion. One group receives a drug to help clear the tissue, while the other group is simply monitored. The goal is to see which method works better and reduces the need for a surgical procedure. About 150 women aged 18-45 will take part, and they will be followed with ultrasounds for up to six weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETAINED PRODUCT OF CONCEPTION AFTER FIRST TRIMESTER MEDICAL ABORTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Meir Medical Center

    RECRUITING

    Kfar Saba, 4861027, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

RETAINED PRODUCT OF CONCEPTION AFTER FIRST TRIMESTER MEDICAL ABORTION RETAINED PRODUCT OF CONCEPTION AFTER FIRST TRIMESTER MEDICAL ABORTION